EM0200
Osteo-Bed Bone Embedding Kit
Sign In to View Organizational & Contract Pricing.
About This Item
NACRES:
NA.47
UNSPSC Code:
12171500
Storage temp.:
room temp
application(s)
hematology
histology
storage temp.
room temp
Application
Suitable for use with large and small mineralized (undecalcified) bone sections. Yields clear, hard blocks for cutting sections. Not water-soluble.
Other Notes
Osteo-Bed Bone Embedding Solvent (O8639) is available to remove plastic from sections.
Kit Components Only
Product No.
Description
- Osteo-Bed Bone Embedding Resin A (O8514) 900 mL
- Osteo-Bed Bone Embedding Catalyst (O8764) 2 x 12
signalword
Danger
target_organs
Respiratory system
Storage Class
5.2 - Organic peroxides and self-reacting hazardous materials
flash_point_f
50.0 °F
flash_point_c
10 °C
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1 - ED ENV 1 - ED HH 1 - Eye Irrit. 2 - Flam. Liq. 2 - Org. Perox. D - Repr. 1B - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Instructions
Nur-Vaizura Mohamad et al.
International journal of medical sciences, 18(16), 3665-3673 (2021-11-19)
Menopause is the leading cause of osteoporosis for elderly women due to imbalanced bone remodelling in the absence of oestrogen. The ability of tocotrienol in reversing established bone loss due to oestrogen deficiency remains unclear despite the plenitude of evidence
Kindlin-2 mediates mechanotransduction in bone by regulating expression of Sclerostin in osteocytes.
Lei Qin et al.
Communications biology, 4(1), 402-402 (2021-03-27)
Osteocytes act as mechanosensors in bone; however, the underlying mechanism remains poorly understood. Here we report that deleting Kindlin-2 in osteocytes causes severe osteopenia and mechanical property defects in weight-bearing long bones, but not in non-weight-bearing calvariae. Kindlin-2 loss in
Colin K Yee et al.
Clinical & experimental metastasis, 25(8), 903-911 (2008-09-25)
In the current study, we examine heparin's anti-metastatic properties by using a well-defined mouse model of osteolytic bone metastasis. C57BL/6 mice were treated with increasing doses of unfractionated heparin (15, 20, or 25 units/mouse) 30 min prior to the left
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EM0200-1KT | 04061833609439 |